150 related articles for article (PubMed ID: 33891969)
1. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
[TBL] [Abstract][Full Text] [Related]
2. The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway.
Wang T; Sun X; Cui H; Liu K; Zhao J
Mol Med Rep; 2020 Mar; 21(3):1097-1106. PubMed ID: 32016456
[TBL] [Abstract][Full Text] [Related]
3. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats.
Wang T; Xie YQ; Miao GX; Cui HP; Liu K; Li Y; Li Y; Zhao J
Life Sci; 2020 Apr; 247():117421. PubMed ID: 32061865
[TBL] [Abstract][Full Text] [Related]
4. Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway.
Zhao J; Miao G; Wang T; Li J; Xie L
Life Sci; 2020 Dec; 262():118551. PubMed ID: 33038370
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits.
Yu QQ; Cheng DX; Xu LR; Li YK; Zheng XY; Liu Y; Li YF; Liu HL; Bai L; Wang R; Fan JL; Liu EQ; Zhao SH
Acta Pharmacol Sin; 2020 Apr; 41(4):546-553. PubMed ID: 31685976
[TBL] [Abstract][Full Text] [Related]
6. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
7. Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway.
Cui H; Lin Y; Xie L; Zhao J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604686
[TBL] [Abstract][Full Text] [Related]
8. Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway.
Li Y; Guo Z; Cui H; Wang T; Xu Y; Zhao J
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328202
[TBL] [Abstract][Full Text] [Related]
9. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
[TBL] [Abstract][Full Text] [Related]
10. The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway.
Zhou W; Wang W; Yuan XJ; Xiao CC; Xing Y; Ye SD; Liu Q
Oxid Med Cell Longev; 2022; 2022():3046777. PubMed ID: 35082965
[TBL] [Abstract][Full Text] [Related]
11. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
[TBL] [Abstract][Full Text] [Related]
12. Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.
Zhao J; Ding W; Song N; Dong X; Di B; Peng F; Tang C
Regul Pept; 2013 Mar; 182():53-8. PubMed ID: 23403244
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice.
Liang DY; Liu LM; Ye CG; Zhao L; Yu FP; Gao DY; Wang YY; Yang ZW; Wang YY
PLoS One; 2014; 8(6):e64895. PubMed ID: 23755157
[TBL] [Abstract][Full Text] [Related]
14. The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells.
Liu LM; Liang DY; Ye CG; Tu WJ; Zhu T
PLoS One; 2015; 10(3):e0121383. PubMed ID: 25803040
[TBL] [Abstract][Full Text] [Related]
15. Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.
Rodríguez-Moyano M; Díaz I; Dionisio N; Zhang X; Avila-Medina J; Calderón-Sánchez E; Trebak M; Rosado JA; Ordóñez A; Smani T
Cardiovasc Res; 2013 Nov; 100(2):297-306. PubMed ID: 23933581
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin III Induces JAK2/STAT3 Leading to IL-6 Production in Rat Vascular Smooth Muscle Cells.
Alanazi AZ; Clark MA
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703282
[TBL] [Abstract][Full Text] [Related]
17. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
19. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway.
Wei P; Tian K; Liu H; Li K; Alam N; Cheng D; Li M; He X; Guo J; Wang R; Wang W; Bai L; Liu E; Xu B; Li Y; Zhao S
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167170. PubMed ID: 38631407
[TBL] [Abstract][Full Text] [Related]
20. Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.
Zhao J; Zhang SF; Shi Y; Ren LQ
Bosn J Basic Med Sci; 2013 May; 13(2):78-83. PubMed ID: 23725502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
